BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36170840)

  • 21. Myelination and mTOR.
    Figlia G; Gerber D; Suter U
    Glia; 2018 Apr; 66(4):693-707. PubMed ID: 29210103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of arginyl-tRNA-protein transferase in oligodendrocytes impairs central nervous system myelination.
    Palandri A; Bonnet LV; Farias MG; Hallak ME; Galiano MR
    Glia; 2022 Feb; 70(2):303-320. PubMed ID: 34669233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The progeroid gene BubR1 regulates axon myelination and motor function.
    Choi CI; Yoo KH; Hussaini SM; Jeon BT; Welby J; Gan H; Scarisbrick IA; Zhang Z; Baker DJ; van Deursen JM; Rodriguez M; Jang MH
    Aging (Albany NY); 2016 Sep; 8(11):2667-2688. PubMed ID: 27922816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
    Kearns CA; Ravanelli AM; Cooper K; Appel B
    J Neurosci; 2015 Nov; 35(44):14861-71. PubMed ID: 26538655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
    Hussien Y; Cavener DR; Popko B
    Glia; 2014 May; 62(5):680-91. PubMed ID: 24481666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin binds RalA and RalB and is required for the thrombin-induced activation of Ral in human platelets.
    Clough RR; Sidhu RS; Bhullar RP
    J Biol Chem; 2002 Aug; 277(32):28972-80. PubMed ID: 12034722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt/mTOR signalling in myelination.
    Norrmén C; Suter U
    Biochem Soc Trans; 2013 Aug; 41(4):944-50. PubMed ID: 23863161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligodendrocyte Development in the Absence of Their Target Axons In Vivo.
    Almeida R; Lyons D
    PLoS One; 2016; 11(10):e0164432. PubMed ID: 27716830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR pathway repressing expression of FoxO3 is a potential mechanism involved in neonatal white matter dysplasia.
    Liu X; Dong C; Liu K; Chen H; Liu B; Dong X; Qian Y; Wu B; Lin Y; Wang H; Yang L; Zhou W
    Hum Mol Genet; 2022 Aug; 31(15):2508-2520. PubMed ID: 35220433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
    Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
    Cells; 2022 May; 11(10):. PubMed ID: 35626682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.
    Narayanan SP; Flores AI; Wang F; Macklin WB
    J Neurosci; 2009 May; 29(21):6860-70. PubMed ID: 19474313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
    Ishii A; Furusho M; Dupree JL; Bansal R
    J Neurosci; 2016 Jun; 36(24):6471-87. PubMed ID: 27307235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
    Furusho M; Ishii A; Bansal R
    J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).
    Xu L; Salloum D; Medlin PS; Saqcena M; Yellen P; Perrella B; Foster DA
    J Biol Chem; 2011 Jul; 286(29):25477-86. PubMed ID: 21622984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RalA functions as an indispensable signal mediator for the nutrient-sensing system.
    Maehama T; Tanaka M; Nishina H; Murakami M; Kanaho Y; Hanada K
    J Biol Chem; 2008 Dec; 283(50):35053-9. PubMed ID: 18948269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of PDK1 in oligodendrocyte lineage cells causes white matter abnormality and myelination defect in the central nervous system.
    Wang H; Liu M; Zou G; Wang L; Duan W; He X; Ji M; Zou X; Hu Y; Yang J; Chen G
    Neurobiol Dis; 2021 Jan; 148():105212. PubMed ID: 33276084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination.
    Grier MD; West KL; Kelm ND; Fu C; Does MD; Parker B; McBrier E; Lagrange AH; Ess KC; Carson RP
    PLoS One; 2017; 12(11):e0188417. PubMed ID: 29161318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.
    Yang Y; Wang H; Zhang J; Luo F; Herrup K; Bibb JA; Lu R; Miller RH
    Dev Biol; 2013 Jun; 378(2):94-106. PubMed ID: 23583582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RalGTPases contribute to Schwann cell repair after nerve injury via regulation of process formation.
    Galino J; Cervellini I; Zhu N; Stöberl N; Hütte M; Fricker FR; Lee G; McDermott L; Lalli G; Bennett DLH
    J Cell Biol; 2019 Jul; 218(7):2370-2387. PubMed ID: 31201266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.